Literature DB >> 8699866

Effect of pentoxifylline on apoptosis of cultured cells.

F Belloc1, C Jaloustre, P Dumain, F Lacombe, M Lenoble, M R Boisseau.   

Abstract

Apoptosis or programmed cell death (PCD) was measured in two human cell models by flow cytometric analysis. Blood neutrophils underwent spontaneous apoptosis in short-term culture. Pentoxifylline (PTX) inhibited spontaneous neutrophil PCD. We confirmed that granulocyte/macrophage colony-stimulating factor (GM-CSF) inhibited apoptosis of polymorphonuclear neutrophils. Treatment with both GM-CSF and PTX did not increase the inhibition of PCD by either GM-CSF or PTX alone. Because apoptosis could be due to the accumulation of H2O2 in the culture medium, and because PTX has been described to reduce peroxide production, we studied the effect of adding catalase to the medium. Catalase reduced the neutrophil apoptosis and this effect was cumulative with the effect of PTX. Camptothecin, an inhibitor of topoisomerase I, induces a block in the S-phase of the cell cycle followed by apoptosis of the U937 cell line. This drug-induced apoptosis was partially inhibited by PTX, whereas the S-phase cell block was not affected. In conclusion, PTX was found to inhibit apoptosis in two different human cell types. In neutrophils, this effect appears to occur regardless of the inhibition of phosphodiesterase activity and inhibition of H2O2 release.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8699866     DOI: 10.1097/00005344-199500252-00015

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  9 in total

1.  Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the community.

Authors:  D J Hetmanski; N J Sparrow; S Curtis; A J Cowley
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

2.  Increased formation of F(2)-isoprostanes in patients with severe heart failure.

Authors:  J L Cracowski; F Tremel; C Marpeau; J P Baguet; F Stanke-Labesque; J M Mallion; G Bessard
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

3.  Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline.

Authors:  D Skudicky; K Sliwa; A Bergemann; G Candy; P Sareli
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

4.  Thalidomide analogue CC-3052 reduces HIV+ neutrophil apoptosis in vitro.

Authors:  M Guckian; I Dransfield; P Hay; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

5.  Effect of pentoxifylline on tumor suppressor and proto-oncogene apoptosis in sperm.

Authors:  David T Maxwell; John D Jacobson; Alan King; Philip J Chan
Journal:  J Assist Reprod Genet       Date:  2002-06       Impact factor: 3.412

6.  Effects of pentoxifylline in adriamycin-induced renal disease in rats.

Authors:  Yusuf Usta; Ugur Burcin Ismailoglu; Aysin Bakkaloglu; Dicle Orhan; Nesrin Besbas; Inci Sahin-Erdemli; Seza Ozen
Journal:  Pediatr Nephrol       Date:  2004-06-16       Impact factor: 3.714

Review 7.  Immunological mechanisms of pentoxifylline in chronic heart failure.

Authors:  Steven M Shaw; Mohammed K H Shah; Simon G Williams; James E Fildes
Journal:  Eur J Heart Fail       Date:  2009-02       Impact factor: 15.534

8.  Cyclooxygenase (COX)-2 and granulosa cell apoptosis in vitro.

Authors:  Angela S Caffrey; William C Patton; Johannah U Corselli; Ron E Swensen; Alan King; Philip J Chan
Journal:  J Assist Reprod Genet       Date:  2002-12       Impact factor: 3.412

9.  Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial.

Authors:  David Wayne Johnson; Carmel Mary Hawley; Brenda Rosser; Elaine Beller; Charles Thompson; Robert G Fassett; Paolo Ferrari; Stephen MacDonald; Eugenie Pedagogos; Alan Cass
Journal:  BMC Nephrol       Date:  2008-08-01       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.